HIV/HBV, HIV/HCV and HIV/HTLV-1 co infection among injecting drug user patients hospitalized at the infectious disease ward of a training hospital in Iran

Pakistan Journal of Medical Sciences

Volumn 23, Issue 4, 2007, Pages 510-513

  Alavi, Seyed Mohammad ^a,b   Etemadi, Arash ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE   (Iran)

Author keywords

Co infection; Hepatitis B virus; Hepatitis C virus; HIV; HTLV 1; Injecting drug user (IDU)

Indexed keywords

DIAMORPHINE; MEMBRANE ANTIGEN; VIRUS ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRUG USE; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEROIN DEPENDENCE; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; IRAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; PREVALENCE; RISK FACTOR; WARD; WESTERN BLOTTING;

EID: 34548378742     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Razzaghi EM, Movaghar AR, Green TC, Khoshnood K. A qualitative study of injecting drug users in Tehran, Iran. Harm Reduct J 2006;18, 3:12.
2. Vazirian M, Nassirimanesh B, Zamani S, Ono-Kihara M, Kihara M, Ravari SM, et al. Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: A cross-sectional study. Harm Reduct J 2005;7:2:19.
3. Pando MA, Bautista CT, Maulen S, Duranti R, Marone R, Rey J. Epidemiology of human immunodeficiency virus, viral hepatitis (B and C), treponema pallidum, and human T-cell lymphotropic I/II virus among men who have sex with men in Buenos Aires, Argentina. Sex Transm Dis 2006;33(5):307-13.
4. Polsky B, Kim AY, Chung RT. Human immunodeficiency virus and hepatitis B and C co infection: Pathogenic interactions, natural history and therapy. AIDS Clin Rev 2000-2001;263-306.
5. Dore GJ, Cooper DA. The impact of HIV therapy on co infection with hepatitis B and hepatitis C viruses. Curr Opin Infect Dis 2001;14:749-55.
6. Puoti M, Airoldi M, Bruno R. Hepatitis B co-infection in human immunodeficiency virus-infected subjects. AIDS Rev 2002;4:27-35.
7. Benhamou Y, Bochet M, Di Martino V. Liver fibrosis progression in human immunodeficiency virus and hepatitis-C virus co infected patients. Hepatology 1999;30:1054-8.
8. Pol S, Vallet-Pritchard A, Fontaine H. Hepatitis C and human immune deficiency co infection at the era of highly active antiretroviral therapy. J Viral Hepatitis 2002;9:1-8.
9. Sulkowski MS, Moore RD, Mehta SH, Chiasson RE, Thomas DL. Hepatitis C and progression of HIV disease. JAMA 2002;288:199-206.
10. Sabin CA, Telfer P, Phillips AN, Bhagani S, Lee CA. The association between hepatitis C virus genotype and human immunodeficiency virus. Disease progression in a cohort of hemophilic men. J Infect Dis 1997;175:164-8.
11. Highleyman L. HIV and hepatitis C co infection. BETA. 2003;15(4):32-44.
12. Setayesh HR. Country assesments, Islamic Republic of Iran, UNAIDS/WHO report, 2006.
13. Gezairy HA. WHO Eastern Mediterranean region report. Geneca WHO, 2000.
14. Khani M, Vakili MM. Prevalence and risk factors of HIV, Hepatitis B virus and Hepatitis C virus infections in drug addicts among Zanjan prisoners. Arch Iranian Med 2003;6(1):1-4.
15. th National Symposium on Hepatitis B and C. Melbourne, Australia. November 2002.
16. Thomas DL. Hepatitis C and human immunodeficiency virus infection. Hepatology 2002;36(Suppl. 1):S20-S9.
17. Francisci D, Baldelli F, Papili R, Stagni G, Pauluzzi S. Prevalence of HBV, HDV and HCV hepatitis markers in HIVpositivepatients. Eur J Epidemiol 1995;11:123-6.
18. Puig-Basagoiti F, Cabana M, Guilera M. Prevalence and route of transmission of infection with a novel DNA virus(TTV), hepatitis C virus, and hepatitis G virus in patients infected with HIV. J AIDS 2000;23:89-94.
19. Dai CYYuML, Chuang WL, Lin ZY. Influence of hepatitis C virus on the profiles of patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol 2001;16:636-40.